advanced lung carcinoma

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Lung Carcinoma Trial in Beijing (LK101 injection (personlized neoantigen pulsed DC vaccine ), Pembrolizumab,

Recruiting
  • Advanced Lung Carcinoma
  • LK101 injection (personlized neoantigen pulsed DC vaccine )
  • +2 more
  • Beijing, Beijing, China
    Cancer hospital Chinese Academy of Medical Sciences
May 23, 2023

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Advanced Lung Carcinoma, Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte (Psychosocial

Active, not recruiting
  • Advanced Lung Carcinoma
  • +6 more
  • Psychosocial Care Conquer Fear Support intervention (psychoeducation, attention training, worry management, and detached mindfulness components)
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Advanced Lung Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Jacksonville (Best Practice,

Recruiting
  • Advanced Lung Carcinoma
  • +2 more
  • Best Practice
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 6, 2022

Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte

Active, not recruiting
  • Advanced Lung Carcinoma
  • +8 more
  • Educational Intervention
  • Duarte, California
    City of Hope Medical Center
Jun 3, 2022

Advanced Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Columbus (Behavioral, Psychological or

Recruiting
  • Advanced Lung Carcinoma
  • +4 more
  • Behavioral, Psychological or Informational Intervention
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

Recruiting
  • Advanced Lung Carcinoma
  • +16 more
  • Anti-CTLA4 Monoclonal Antibody BMS-986218
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Advanced Lung Carcinoma Trial in China (TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for

Recruiting
  • Advanced Lung Carcinoma
  • TQB3616 capsules
  • +2 more
  • Chongqing, Chongqing, China
  • +6 more
Sep 18, 2021

Advanced Lung Carcinoma, NSCLC Trial (Anti-PD-1/PD-L1 Monoclonal Antibody,Chemotherapy, Bronchoscopy-assisted Interventional

Not yet recruiting
  • Advanced Lung Carcinoma
  • Non-small Cell Lung Cancer
  • Anti-PD-1/PD-L1 Monoclonal Antibody,Chemotherapy
  • Bronchoscopy-assisted Interventional Therapy
  • (no location specified)
Jan 7, 2021